Drug	Gene	Type	Source
(3s,8s,9s,10r,13r,14s,17r)-17-(1,5-dimethylhex-4-enyl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-ol	CYP27A1	Text_Mining(increases(metabolic processing))	CTD
(3s,8s,9s,10r,13r,14s,17r)-17-(1,5-dimethylhex-4-enyl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-ol	DHCR24	Text_Mining(increases(metabolic processing))	CTD
(3s,8s,9s,10r,13r,14s,17r)-17-(1,5-dimethylhex-4-enyl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-ol	DHCR24	Text_Mining(increases(abundance))	CTD
(3s,8s,9s,10r,13r,14s,17r)-17-(1,5-dimethylhex-4-enyl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-ol	NR1H2	Activity=None(Unspecified)	D4 ChEMBL
(3s,8s,9s,10r,13r,14s,17r)-17-(1,5-dimethylhex-4-enyl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-ol	NR1H3	Activity=None(Unspecified)	D4 ChEMBL